FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer-Reference-Cited by-同舟云学术

FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer

Published:2020-10 Issue:4 Volume:38 Page:534-550.e9
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Arruabarrena-Aristorena Amaia^ORCID,Maag Jesper L.V.,Kittane Srushti,Cai Yanyan,Karthaus Wouter R.,Ladewig Erik^ORCID,Park Jane,Kannan Srinivasaraghavan,Ferrando Lorenzo,Cocco Emiliano,Ho Sik Y.,Tan Daisylyn S.,Sallaku Mirna,Wu Fan,Acevedo Barbara,Selenica Pier,Ross Dara S.,Witkin Matthew,Sawyers Charles L.,Reis-Filho Jorge S.,Verma Chandra S.,Jauch Ralf,Koche Richard,Baselga José,Razavi Pedram,Toska Eneda,Scaltriti Maurizio

Funder

Memorial Sloan-Kettering Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference91 articles.

1. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes;Adams;Nature,2019

2. Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese;Akamatsu;Nat. Genet.,2012

3. The ENCODE blacklist: identification of problematic regions of the genome;Amemiya;Sci. Rep.,2019

4. HTSeq—a Python framework to work with high-throughput sequencing data;Anders;Bioinformatics (Oxford, England),2015

5. Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence;Balko;Sci. Transl. Med.,2016

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive study on epigenetic signatures to monitor disease progression and the response to therapy in breast cancer;Biomedical Analysis;2024-09

2. Application and prospect of organoid technology in breast cancer;Frontiers in Immunology;2024-08-26

3. Discovering mechanisms of human genetic variation and controlling cell states at scale;Trends in Genetics;2024-07

4. The Role of FOXA1 in Human Normal Development and Its Functions in Sex Hormone-Related Cancers;Frontiers in Bioscience-Landmark;2024-06-21

5. Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents;British Journal of Cancer;2024-06-20